<a href='https://www.zacks.com/stock/news/2113903/sanofi-sny-gains-but-lags-market-what-you-should-know'>Sanofi  ( SNY )  Gains But Lags Market: What You Should Know --Zacks Commentary</a><br></br><a href='https://www.benzinga.com/general/biotech/23/06/33018311/sanofis-amlitelimab-hits-primary-goal-in-mid-stage-atopic-dermatitis-study'>Sanofi's Amlitelimab Hits Primary Goal In Mid-Stage Atopic Dermatitis Study - Sanofi  ( NASDAQ:SNY )  --Benzinga</a><br></br><a href='https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-reaffirms-target-deliver-over-109-bln-annual-vaccine-sales-by-2030-2023-06-29/'>Sanofi reaffirms target to deliver over $10.9 bln in annual vaccine sales by 2030 --Reuters</a><br></br><a href='https://www.zacks.com/stock/news/2114422/sanofi-sny-atopic-dermatitis-drug-meets-goals-in-phase-ii-study'>Sanofi  ( SNY )  Atopic Dermatitis Drug Meets Goals in Phase II Study --Zacks Commentary</a><br></br><a href='https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-says-its-back-drawing-board-mrna-flu-vaccines-2023-06-29/'>Sanofi says it's back to the drawing board on mRNA flu vaccines --Reuters</a><br></br><a href='https://www.globenewswire.com/news-release/2023/06/29/2696706/0/en/Press-Release-Vaccines-R-D-pipeline-raises-the-bar-in-RSV-influenza-meningitis-and-pneumococcal-disease.html'>Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease --GlobeNewswire</a><br></br><a href='https://www.benzinga.com/pressreleases/23/06/n33069980/sk-bioscience-sanofi-announce-positive-results-from-phase-ii-study-of-21-valent-pneumococcal-conju'>SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate --Benzinga</a><br></br><a href='https://www.barrons.com/articles/drug-costs-pricing-dogs-humans-1479e10e'>A Drug for Itchy Dogs Costs $1,200. Why Is the Human Equivalent $43,000? --Barrons</a><br></br>